Advanced HIV Disease
Cross-source consensus on Advanced HIV Disease from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Highlighted claims
- CD4 count below 200 cells/mm³ is a marker of advanced HIV disease. — Survival and predictors of mortality among people living with HIV (PLHIV) on antiretroviral therapy in Ethiopia (2016–2023): a retrospective cohort study
- As CD4 count falls, susceptibility to infections rises. — Survival and predictors of mortality among people living with HIV (PLHIV) on antiretroviral therapy in Ethiopia (2016–2023): a retrospective cohort study
- WHO stage IV reflects advanced HIV disease with major immune damage and vulnerability to opportunistic infections. — Survival and predictors of mortality among people living with HIV (PLHIV) on antiretroviral therapy in Ethiopia (2016–2023): a retrospective cohort study
- Late presentation and advanced disease markers were among the strongest drivers of mortality. — Survival and predictors of mortality among people living with HIV (PLHIV) on antiretroviral therapy in Ethiopia (2016–2023): a retrospective cohort study